IBDEI1D0 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,21723,2)
 ;;=^5138934
 ;;^UTILITY(U,$J,358.3,21724,0)
 ;;=N52.32^^99^1106^13
 ;;^UTILITY(U,$J,358.3,21724,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21724,1,3,0)
 ;;=3^Erectile Dysfunction After Radical Cystectomy
 ;;^UTILITY(U,$J,358.3,21724,1,4,0)
 ;;=4^N52.32
 ;;^UTILITY(U,$J,358.3,21724,2)
 ;;=^5015758
 ;;^UTILITY(U,$J,358.3,21725,0)
 ;;=N52.31^^99^1106^14
 ;;^UTILITY(U,$J,358.3,21725,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21725,1,3,0)
 ;;=3^Erectile Dysfunction After Radical Prostatectomy
 ;;^UTILITY(U,$J,358.3,21725,1,4,0)
 ;;=4^N52.31
 ;;^UTILITY(U,$J,358.3,21725,2)
 ;;=^5015757
 ;;^UTILITY(U,$J,358.3,21726,0)
 ;;=N52.34^^99^1106^15
 ;;^UTILITY(U,$J,358.3,21726,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21726,1,3,0)
 ;;=3^Erectile Dysfunction After Simple Prostatectomy
 ;;^UTILITY(U,$J,358.3,21726,1,4,0)
 ;;=4^N52.34
 ;;^UTILITY(U,$J,358.3,21726,2)
 ;;=^5015760
 ;;^UTILITY(U,$J,358.3,21727,0)
 ;;=N52.33^^99^1106^16
 ;;^UTILITY(U,$J,358.3,21727,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21727,1,3,0)
 ;;=3^Erectile Dysfunction After Urethral Surgery
 ;;^UTILITY(U,$J,358.3,21727,1,4,0)
 ;;=4^N52.33
 ;;^UTILITY(U,$J,358.3,21727,2)
 ;;=^5015759
 ;;^UTILITY(U,$J,358.3,21728,0)
 ;;=N52.01^^99^1106^17
 ;;^UTILITY(U,$J,358.3,21728,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21728,1,3,0)
 ;;=3^Erectile Dysfunction d/t Arterial Insufficiency
 ;;^UTILITY(U,$J,358.3,21728,1,4,0)
 ;;=4^N52.01
 ;;^UTILITY(U,$J,358.3,21728,2)
 ;;=^5015752
 ;;^UTILITY(U,$J,358.3,21729,0)
 ;;=N52.1^^99^1106^18
 ;;^UTILITY(U,$J,358.3,21729,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21729,1,3,0)
 ;;=3^Erectile Dysfunction d/t Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,21729,1,4,0)
 ;;=4^N52.1
 ;;^UTILITY(U,$J,358.3,21729,2)
 ;;=^5015755
 ;;^UTILITY(U,$J,358.3,21730,0)
 ;;=F42.4^^99^1106^23
 ;;^UTILITY(U,$J,358.3,21730,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21730,1,3,0)
 ;;=3^Excoriation (Skin-Picking) Disorder
 ;;^UTILITY(U,$J,358.3,21730,1,4,0)
 ;;=4^F42.4
 ;;^UTILITY(U,$J,358.3,21730,2)
 ;;=^5138446
 ;;^UTILITY(U,$J,358.3,21731,0)
 ;;=I50.84^^99^1106^3
 ;;^UTILITY(U,$J,358.3,21731,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21731,1,3,0)
 ;;=3^End Stage Heart Failure
 ;;^UTILITY(U,$J,358.3,21731,1,4,0)
 ;;=4^I50.84
 ;;^UTILITY(U,$J,358.3,21731,2)
 ;;=^5151391
 ;;^UTILITY(U,$J,358.3,21732,0)
 ;;=A04.71^^99^1106^5
 ;;^UTILITY(U,$J,358.3,21732,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21732,1,3,0)
 ;;=3^Enterocolitis d/t Clostridium Difficile,Recurrent      
 ;;^UTILITY(U,$J,358.3,21732,1,4,0)
 ;;=4^A04.71
 ;;^UTILITY(U,$J,358.3,21732,2)
 ;;=^5151291
 ;;^UTILITY(U,$J,358.3,21733,0)
 ;;=A04.72^^99^1106^6
 ;;^UTILITY(U,$J,358.3,21733,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21733,1,3,0)
 ;;=3^Enterocolitis d/t Clostridium Difficile,Not Specf as Recurrent
 ;;^UTILITY(U,$J,358.3,21733,1,4,0)
 ;;=4^A04.72
 ;;^UTILITY(U,$J,358.3,21733,2)
 ;;=^5151292
 ;;^UTILITY(U,$J,358.3,21734,0)
 ;;=G12.24^^99^1106^30
 ;;^UTILITY(U,$J,358.3,21734,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21734,1,3,0)
 ;;=3^Familial Motor Neuron Disease
 ;;^UTILITY(U,$J,358.3,21734,1,4,0)
 ;;=4^G12.24
 ;;^UTILITY(U,$J,358.3,21734,2)
 ;;=^5151309
 ;;^UTILITY(U,$J,358.3,21735,0)
 ;;=K29.70^^99^1107^3
 ;;^UTILITY(U,$J,358.3,21735,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21735,1,3,0)
 ;;=3^Gastritis, w/o bleeding, unspec
